X4 Pharmaceuticals raises $155.3 million in public offering
PositiveFinancial Markets

X4 Pharmaceuticals has successfully raised $155.3 million through a public offering, a significant boost for the company as it aims to advance its innovative therapies. This funding is crucial for the development of treatments that could potentially improve the lives of patients with rare diseases, highlighting the growing investor confidence in the biotech sector.
— Curated by the World Pulse Now AI Editorial System







